Showing results (111-120 of 425) with videos related to

Sort By:
Pageof 43
Leukemia & Lymphoma|November 24, 2020
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDSBrendan Rasor, Tyler Dickerson, Qiuhong Zhao, et al.
Blood|July 5, 2014
Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cellsYin Wang, Yan Liu, Fei Tang, et al.
The Journal of Investigative Dermatology|March 26, 2015
Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary SyndromeHenry K Wong, Heather Gibson, Timothy Hake, et al.
Cellular Immunology|October 17, 2002
Administration of two macrophage-derived interferon-gamma-inducing factors (IL-12 and IL-15) induces a lethal systemic inflammatory response in mice that is dependent on natural killer cells but does not require interferon-gammaJennifer L Biber, Saad Jabbour, Robin Parihar, et al.
Cancers|January 22, 2021
Unraveling the Role of Innate Lymphoid Cells in AcuteMyeloid LeukemiaMatthew R Lordo, Steven D Scoville, Akul Goel, et al.
Science (New York, N.Y.)|January 8, 2011
Innate or adaptive immunity? The example of natural killer cellsEric Vivier, David H Raulet, Alessandro Moretta, et al.
Leukemia & Lymphoma|June 12, 2024
Impact of chronic graft-versus-host disease on non-relapse mortality and survivalJustin Jiang, Audrey M Sigmund, Qiuhong Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 14, 2022
PDGF-D-PDGFRβ signaling enhances IL-15-mediated human natural killer cell survivalShoubao Ma, Tingting Tang, Xiaojin Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancerManisha H Shah, Aharon G Freud, Don M Benson, et al.
Cancer Research|November 20, 2002
Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomasWeilian Yang, Rolf F Barth, Dianne M Adams, et al.
Pageof 43